688782-45-8

Basic information

• Product Name: 2-Pyrimidinamine, 4-chloro-6-(4-methoxyphenyl)-
• CAS NO: 688782-45-8
• Molecular Formula: C11H10ClN3O
• Molecular Weight: 235.673
• Mol File: 688782-45-8.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 2-Pyrimidinamine, 4-chloro-6-(4-methoxyphenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyrimidinamine, 4-chloro-6-(4-methoxyphenyl)-(688782-45-8)
• EPA Substance Registry System: 2-Pyrimidinamine, 4-chloro-6-(4-methoxyphenyl)-(688782-45-8)

Safety Data

• Hazardous Substances Data: 688782-45-8(Hazardous Substances Data)

Upstream product

• 56-05-3 2-Amino-4,6-dichloropyrimidine 
• 5720-07-0 4-methoxyphenylboronic acid 
• 2881-83-6 ethyl 4-methoxybenzoylacetate 
• 98305-81-8 2-amino-6-(4-methoxyphenyl)pyrimidin-4-ol 

Downstream Products

• 54806-91-6 4-methoxy-6-(4-methoxyphenyl)pyrimidin-2-amine 
• 1374960-36-7 N-(2-amino-6-(4-methoxyphenyl)pyrimidin-4-yl)methanesulfonamide 
• 59807-19-1 4-(4-methoxyphenyl)-6-phenylpyrimidin-2-ylamine 
• 1123744-75-1 4-(4-methoxyphenyl)-6-(p-tolyl)pyrimidin-2-amine 
• 1186410-29-6 5-amino-7-(4-methoxyphenyl)-2-(phenylmethyl)-1,2,4-triazolo[4,3-c]pyrimidin-3(2H)-one 
• 1303471-57-9 C₁₈H₁₉N₅O 
• 1303471-48-8 C₁₁H₁₃N₅O 
• 881193-00-6 N₄-(3-chloro-4-methoxy-phenyl)-6-(4-methoxy-phenyl)-pyrimidine-2,4-diamine 

Relevant articles and documents

Influence of the C-5 substitution in polysubstituted pyrimidines on inhibition of prostaglandin E2 production

As a part of a broader structure-activity relationship study of substituted 2-aminopyrimidines, the influence of the C-5 substitution on inhibition of prostaglandin E2 (PGE2) production was studied. Thirty compounds were prepared sta

Potent and selective adenosine A2A receptor antagonists: [1,2,4]-triazolo[4,3-c]pyrimidin-3-ones

Antagonism of the adenosine A2A receptor affords a possible treatment of Parkinson's disease. In the course of investigating pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine A2A antagonists, we prepared [1,2,4]-triazolo[4,3-c]pyrimidi

PYRIMIDINE DERIVATIVES FOR TREATMENT OF HYPERPROLIFERATIVE DISORDERS

Pyrimidine derivatives of formula (I) in which J and Y represent aromatic or heteroaromatic rings; R2, G, G', and G" represent substituent groups and R2a represents H or halogen; L represents a linking group; and M represents CH or N. Pharmaceutical compositions containing these compounds, and methods of using these compounds in treatment of hyperproliferative diseases such as cancer are also disclosed and claimed.